Life-Threatening Complications of Hepatitis B Virus-Related Polyarteritis Nodosa Developing Despite Interferon-α2b Therapy: Successful Treatment with a Combination of Interferon, Lamivudine, Plasma Exchanges and Steroids

2001 ◽  
Vol 20 (4) ◽  
pp. 290-292 ◽  
Author(s):  
P. Dele´aval ◽  
P. Stadler ◽  
E. Descombes ◽  
E. Hecker ◽  
G. Schrago ◽  
...  
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Successful Treatment ◽  
Polyarteritis Nodosa ◽  
B Virus ◽  
Life Threatening ◽  
Interferon Α2b

Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine

2000 ◽  
Vol 33 (4) ◽  
pp. 677-683 ◽  
Author(s):  
Andreas Erhardt ◽  
Abdurrahman Sagir ◽  
Loic Guillevin ◽  
Eva Neuen-Jacob ◽  
Dieter Haussinger
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Successful Treatment ◽  
Polyarteritis Nodosa ◽  
Alpha Interferon ◽  
B Virus

Polyarteritis Nodosa Following Vaccination Against Hepatitis B Virus with Lower-Extremity Manifestations: A Case Report

2019 ◽  
Vol 109 (3) ◽  
pp. 241-245
Author(s):  
Daniel R. Wright ◽  
Jenni M. Davis ◽  
Karl Robstad ◽  
Melissa D. Shah ◽  
Michael C. Keller ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatitis B Virus ◽  
Virus Infection ◽  
Hepatitis B ◽  
Polyarteritis Nodosa ◽  
Peripheral Nerves ◽  
Hepatitis B Virus Infection ◽  
Multiple Organs ◽  
B Virus ◽  
Life Threatening

Polyarteritis nodosa is a progressive, often life-threatening, vasculitis affecting multiple organs, including the skin and peripheral nerves. We report a patient presenting with systemic features of the disease and with characteristic lesions in the feet 3 weeks after vaccination against hepatitis B virus infection.

Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, α-interferon and lamivudine

2000 ◽  
Vol 33 (4) ◽  
pp. 677-683 ◽  
Author(s):  
Andreas Erhardt ◽  
Abdurrahman Sagir ◽  
Loic Guillevin ◽  
Eva Neuen-Jacob ◽  
Dieter Häussinger
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Successful Treatment ◽  
Polyarteritis Nodosa ◽  
B Virus

scholarly journals Prolonged and biphasic acute hepatitis A in hepatitis B virus carrier

2016 ◽  
Vol 10 ◽  
Author(s):  
Elena Garlatti Costa ◽  
Michela Ghersetti ◽  
Silvia Grazioli ◽  
Pietro Casarin
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
Inactive Carrier ◽  
B Virus ◽  
Acute Hepatitis A ◽  
Hepatitis B Virus Carrier ◽  
Life Threatening

Acute hepatitis A is generally a self-limited disease in healthy subjects within few weeks, but an uncommon type of prolonged and biphasic acute course of hepatitis A infection has been also described. This type of presentation is observed in about 6-10% of patients, but a small number of reports, concerning this topic, are available in literature. In addition hepatitis A virus (HAV) infection in hepatitis B virus (HBV) carriers has rarely been discussed. A 41-year-old Italian man, already known to our Department for HBV infection as an inactive carrier HBsAg(+)ve, experienced a prolonged and biphasic course of acute hepatitis A, lasting about 7 months. In this patient possible factors, causing the second flare of transaminases, were excluded (in particular autoimmunity). Liver biopsy as well HAV RNA search in blood/stools were not performed. In conclusion, the hepatologist should take into account this type of atypical course in patients with HAV-related hepatitis and should promote HAV vaccination in subjects with HBV-chronic hepatitis, to prevent possible life-threatening acute exacerbation of hepatic damage, mainly in HBV-carriers with more severe forms of liver diseases.

scholarly journals Prevalence of Hepatitis B among Food Vendors in Wurukum Market, Makurdi Benue State

2018 ◽  
pp. 1-5
Author(s):  
V. U. Obisike ◽  
C. M. Uke ◽  
E. U. Amuta
Keyword(s):  
Risk Factors ◽  
Liver Disease ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Age Groups ◽  
Hbv Infection ◽  
Test Strips ◽  
Significant Difference ◽  
B Virus ◽  
Life Threatening

Hepatitis B is a life threatening infectious liver disease caused by hepatitis B virus (HBV). The aim of this study was to determine the prevalence of HBV among food vendors in Wurukum, a highly commercial section of metropolitan Makurdi in Benue State. The test was carried out with the use of an immunochromatographic  micropoint HBsAg test strips and a HBsAg  buffer screen for the virus. Out of the 250 non-vaccinated food vendors sampled, 27(10.8%) had HBV infection, with more in males (21.7%) than in females (6.6%). No significant difference (p>0.05) was found among age groups in spite of the observed highest prevalence of 14.3% among the 20-29 year olds. Therefore, the need for routine screening cannot be overemphasized in spite of known risk factors among food vendors.

Sign in / Sign up

Export Citation Format

Share Document